WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2015

Nov 23, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2015-11-19

Reporting Person: MILLER GEORGE LLOYD (Sr. VP, GC & Corp. Sec.)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-11-19	Common Stock	A	6421.0000	$0.0000	Acquired	8226.6060	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-11-19	Stock Option (Right to Buy)	$62.3000	A	15724.0000	Acquired	2025-11-19	Common Stock (15724.0000)	Direct
2015-11-19	Stock Option (Right to Buy)	$62.3000	A	7860.0000	Acquired	2025-11-19	Common Stock (7860.0000)	Direct